ALK-rearrangements and testing methods in non-small cell lung cancer: a review - Wikidata - wikimedia - TriplyDB

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

http://www.wikidata.org/entity/Q33776835

about

Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK Epigenetics in non-small cell lung cancer: from basics to therapeutics Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib Anaplastic lymphoma kinase: Role in cancer and therapy perspective.The liquid biopsy in lung cancer AZD0530 sensitizes drug-resistant ALK-positive lung cancer cells by inhibiting SRC signaling.Role and targeting of anaplastic lymphoma kinase in cancer.S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.Lung cancer prediction using neural network ensemble with histogram of oriented gradient genomic features.Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65.

P2860

Q24308008-839B8AA6-35B9-44C8-ADF7-4C41AA82116A Q26749113-E400E97E-9BC4-4810-8719-80ACFC732A2D Q26775817-9D3A09BD-C1D4-49B4-9C74-A3AB8BBA8D32 Q38623421-AEE0F643-7D8F-4265-A8DD-ECB1342F2619 Q39132753-D00F8A99-4EC6-4D25-9B9D-30BA4ED84159 Q42293026-4D4C3CF8-065D-4EA3-9C2B-50BD6D13911D Q49888052-7EC5A364-2FF8-4526-A3C9-1D4410C35CF4 Q49959205-14927A4B-163B-4AE3-9D25-5B8DC90FB152 Q53805421-AA58FCA2-D478-42EA-BB45-C0A897FA23C4 Q55161381-2E183B92-0E51-4CE3-89C8-B5C5954C2DA5

P2860

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

http://www.wikidata.org/entity/Q33776835

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

@ast

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

@en

type

label

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

@ast

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

@en

prefLabel

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

@ast

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

@en

P1433

Q33776835-F3570966-F367-4844-A5A2-D381FCC7E6A8

P1476

Q33776835-4CF19FF6-B4DD-4515-B69D-C50C9982285B

P2093

Q33776835-33225223-B775-4702-82FD-EC07091952DA

Q33776835-790B38D9-1157-4717-905E-0DD2BA6A7F6D

Q33776835-B50DE587-A909-4904-AE5F-A4BA27426339

Q33776835-E0E089A8-7035-4592-A29C-1FEDC386566B

P2860

Q33776835-01F841C7-3118-497F-8538-79A168499A82

Q33776835-03C6B1E9-3CE9-427D-BFA4-427D0919FA04

Q33776835-05F4022B-6D7B-4EB4-A929-C3221040D5D4

Q33776835-0AB2C97F-C8D8-4D62-8A3D-156812F2B4D1

Q33776835-16E02A47-5422-4E51-BC49-90F3F9BA2017

Q33776835-17CF253D-A7C3-4FDD-89D8-F964EEF36A68

Q33776835-17E758D3-8A37-4FF1-8C2D-4BEBE8EC5FD2

Q33776835-1B381EB2-A883-4BAB-90F2-C94AF30CF930

Q33776835-1DFA493A-FF05-49B6-80AB-82EC171D37D8

Q33776835-1E16F344-DB1F-4BEF-9C9A-740C4CFEE31C

P304

Q33776835-3A2BF411-EF52-4EFE-8A7D-ED84BC8E5D3C

P31

Q33776835-5602893A-6237-4FE4-8951-4ABCB402ECC5

P356

Q33776835-36F9BACA-C435-4E88-ABE9-3A79A89E6233

P433

Q33776835-B0724F0E-C70A-4721-B085-D5C2A33EE58E

P478

Q33776835-D43991FB-9144-4267-B5E9-6E5B9CF0DC87

P577

Q33776835-2E47CF55-3A13-478D-99AB-AFFE73B0B97E

P698

Q33776835-6760B4B8-3B5C-446C-9630-F63E09FF3258

P932

Q33776835-B90B6605-7AF4-4CE0-86D9-47DFB466B93A

P356

GENESANDCANCER.3

P1433

P1476

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

@en

P2093

James Cotelingam

http://www.w3.org/2001/XMLSchema#string

Kim Mayhall

http://www.w3.org/2001/XMLSchema#string

Moiz Vora

http://www.w3.org/2001/XMLSchema#string

Rodney E Shackelford

http://www.w3.org/2001/XMLSchema#string

P2860

SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas

Cancer genome landscapes

Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling

Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

The biology and treatment of EML4-ALK non-small cell lung cancer

Somatic mutations affect key pathways in lung adenocarcinoma

Identification of ALK as a major familial neuroblastoma predisposition gene

Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/GENESANDCANCER.3

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24955213

http://www.w3.org/2001/XMLSchema#string

P932

4063252

http://www.w3.org/2001/XMLSchema#string